NASDAQ
3.85USD
-0.07 (-1.79%)
We have scored 18 news catalysts on CAMP4 Therapeutics Corporation (CAMP) over the past 12 months. The biggest single-day move next to one of them came Dec 5, 2025, when CAMP closed −4.1%: “Canadian GoldCamps Provides Update on Definitive Agreement to Acquire 70% interest in Murphy Lake Property”. Coverage across the window leans mixed (average ticker sentiment −0.05). Most of the impact sits in price momentum and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
81.8M
P/E
—
EPS
—
Beta
0.21
52W range
2.85-7.75
Day range
3.73–3.94
Open
3.86
Prev close
3.92
Volume
116.9K
Avg volume
244.9K
Dividend
0.00
IPO
2024-10-11
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about CAMP4 Therapeutics Corporation — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for CAMP: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
